Esperion: Revolutionizing the Pharma Industry
Esperion Therapeutics Inc. (NASDAQ: ESPR) is a pharmaceutical company currently focused on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol, or LDL-C. Through the commercial execution and completion of its CLEAR Outcomes trial and the advancement of...
